462 results on '"Schanz U"'
Search Results
2. Autologous hematopoietic stem cell transplantation in multiple sclerosis: a global approval and availability review
3. Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
4. Leukämien und Lymphome
5. Knochenmark- und periphere Blutstammzelltransplantation und andere Methoden des Stammzellersatzes
6. Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
7. Sensitization and desensitization of burn patients as potential candidates for vascularized composite allotransplantation
8. Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation—the Swiss Transplant Cohort Study
9. Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study
10. P1379: OPTIMIZATION OF FLUDARABINE PHARMACOKINCETICS TO REDUCE THE RELAPSE INCIDENCE IN AML PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
11. P379: MUTATIONAL LANDSCAPE IN THERAPY-RELATED ACUTE LYMPHOBLASTIC LEUKEMIA
12. S235: A TWO-PART, SINGLE- AND TWO-ARM RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE S1P RECEPTOR MODULATOR KRP203 IN SUBJECTS WITH HEMATOLOGICAL MALIGNANCIES
13. P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AND CYTOKINE-RELEASE SYNDROME AFTER CD19 CAR-T CELL THERAPY - A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART COALITION
14. Vox Sanguinis International Forum on platelet cryopreservation
15. High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities
16. Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party
17. Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study
18. The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT
19. Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT
20. Is Leukocyte Depletion Important in the Prevention of Alloimmunization by Random Single Donor Platelet Transfusion?
21. Changes of Circulating Antibody Levels Induced by ABO Antibody Adsorption for ABO-Incompatible Kidney Transplantation
22. Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCT
23. ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION FOR NON‐HODGKIN’S LYMPHOMA IN SWITZERLAND. 35 YEARS OF EXPERIENCE 1985‐2020. FOR SBST WORKING GROUP
24. Autologous hematopoietic stem cell transplantation in multiple sclerosis: a global approval and availability review
25. Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial
26. The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable
27. Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
28. Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland
29. Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
30. Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
31. Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults
32. Quality control of a national bone marrow donor registry: results of a pilot study and proposal for a standardized approach
33. Lack of recognition of HLA class I mismatches outside α1/α2 domains by CD8+ alloreactive T lymphocytes: the HLA-B44 paradigm
34. Autologous and allogeneic stem cell transplantation for diffuse large B-cell lymphoma in the last decade. An analysis from the Lymphoma Working Party of the EBMT: O329
35. Late G-CSF after allogeneic bone marrow or peripheral blood stem cell transplantation: a prospective controlled trial
36. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation
37. Delaying treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for hematological malignancies: a prospective randomized trial
38. Transfusion of cryopreserved autologous platelets to overcome HLA alloimmunization in patients with hematological malignancies: V811
39. Comparison of T-cell depletion in haploidentical hematopoietic stem cell transplantation: V778
40. Effects of an outpatient physical exercise intervention on HSCT recipients: N1305
41. Comparison of T-cell depletion in haplo-identical haematopoietic stem cell transplantation: P1081
42. Association of health care expenditure with results of alloHSCT in Europe: P823
43. Low-dose busulfan/full-dose fludarabine-based reduced-intensity conditioning in 30 high-risk paediatric and adult chronic granulomatous disease patients: O170
44. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia: A study of 6,515 cases of AML: V27
45. Orale Karzinome nach Stammzelltransplantation- ein Literaturüberblick über 30 Jahre: PO077
46. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation
47. Severe immune hemolysis and pure red cell aplasia after haploidentical non-myeloablative allogeneic stem cell transplantation: R1251
48. Successful busulfan-based reduced-intensity conditioning in high-risk paediatric and adult chronic granulomatous disease - The Swiss experience: O408
49. Levels of Anti-A/B Antibodies After ABO-Incompatible Hematopoietic Stem Cell Transplantation
50. Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.